A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease

This study has been completed.

Study NCT00412321 Information provided by Centocor, Inc.

First Received: December 15, 2006 Last Updated: December 1, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2011
Estimated Primary Completion Date:	No date given